{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-174933","form_type":"8-K","ticker":"HCA","cik":"0000860730","company_name":"HCA Healthcare, Inc.","filed_at":"2026-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.829254+00:00","generated_at":"2026-05-15T04:20:41.031426+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"HCA Q1 revenue up 4.3% to $19.1B; EPS rises 10.9% to $7.15; declares $0.78 dividend","bullets":["Revenues $19.109B, net income $1.620B (+0.6% YoY); diluted EPS $7.15 (+10.9% YoY).","Adjusted EBITDA $3.802B (+1.9%); cash from operations $2.014B (+22.0%).","Same facility admissions +0.9%; equivalent admissions +1.3% vs Q1 2025.","Quarterly cash dividend of $0.78 per share declared, payable June 30, 2026 to holders of record June 16, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-174933","json":"https://secwatch.observer/filing/0001193125-26-174933.json","markdown":"https://secwatch.observer/filing/0001193125-26-174933.md","text":"https://secwatch.observer/filing/0001193125-26-174933.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860730/000119312526174933/0001193125-26-174933-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860730/000119312526174933/hca-20260424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:20:41.031426+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1abe25919c5784b943a66566ffabbbdc5b8d2904","claim":"HCA Healthcare, Inc. reported first quarter ended March 31, 2026 results: revenue $19.109 billion, net income $1.620 billion, EPS $7.15 per diluted share.","evidence_excerpt":"the first quarter ended March 31, 2026. Key first quarter metrics (all percentage changes compare 1Q 2026 to 1Q 2025 unless otherwise noted): • Revenues increased 4.3 percent to $19.109 billion • Net income attributable to HCA Healthcare, Inc. increased 0.6 percent to $1.620 billion • Diluted earnings per share and diluted earnings per share, as adjusted, increased 10.9","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312526174933/0001193125-26-174933-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Revenue","value":"$19.109 billion"},{"label":"Net income","value":"$1.620 billion"},{"label":"EPS","value":"$7.15 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}